BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12232745)

  • 1. [Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia].
    Hinz P; Lubenow N; Eckernkamp A; Geinacher A
    Unfallchirurg; 2002 Sep; 105(9):845-50. PubMed ID: 12232745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia.
    Farner B; Eichler P; Kroll H; Greinacher A
    Thromb Haemost; 2001 Jun; 85(6):950-7. PubMed ID: 11434701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparin-induced thrombocytopenia--a serious complication within the scope of heparin therapy. Follow-up of 7 trauma surgery patients].
    Kuhn B
    Unfallchirurg; 1997 Aug; 100(8):646-51. PubMed ID: 9381213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lepirudin use in a neonate with heparin-induced thrombocytopenia.
    Nguyen TN; Gal P; Ransom JL; Carlos R
    Ann Pharmacother; 2003 Feb; 37(2):229-33. PubMed ID: 12549954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
    Shantsila E; Lip GYH; Chong BH
    Chest; 2009 Jun; 135(6):1651-1664. PubMed ID: 19497901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
    Schenk JF; Pindur G; Stephan B; Mörsdorf S; Mertzlufft F; Kroll H; Wenzel E; Seyfert UT
    Clin Appl Thromb Hemost; 2003 Jan; 9(1):25-32. PubMed ID: 12643320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: pathophysiology and management.
    Mureebe L; Silver D
    Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.
    Pouplard C; Regina S; May MA; Gruel Y
    Arch Mal Coeur Vaiss; 2007; 100(6-7):563-8. PubMed ID: 17893639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
    Kodityal S; Manhas AH; Udden M; Rice L
    Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
    Macchi L; Sarfati R; Guicheteau M; Chamlian V; Pourrat O; Gruel Y; Magnin G; Brizard A; Boinot C
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):187-9. PubMed ID: 11030522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current treatment concepts in heparin-induced thrombocytopenia].
    Ranze O; Greinacher A
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
    Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
    Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
    Matthai WH
    Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.